Publications by authors named "Wanting Shao"

Claim this Profile
F
Favorable outcome of immunotherapy use in metastatic HR+/HER2- breast cancer: a population-based cohort study.
Guansheng Zhong, Jingjing Hu, Luxin Wei, Bajin Wei, Haidong Cui, Wanting Shao

Int J Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supramolecular chitin-based hydrogels with self-adapting and fast-degradation properties for enhancing wound healing.
Wenwen Shi, Dongqin Zhang, Luyao Han, Wanting Shao, Qimeng Liu

Carbohydr Polym· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degradation of chloromethylisothiazolinone antimicrobial by Vacuum-Ultraviolet/Ultraviolet irradiation: Reactive species, degradation pathway and toxicity evaluation.
Nan Huang, Wan-Ting Shao, Qi Wang, Wen-Long Wang, Qian-Yuan Wu

Chemosphere· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Removal of methylisothiazolinone biocide from wastewater by VUV/UV advanced oxidation process: Kinetics, mechanisms and toxicity.
Nan Huang, Wan-Ting Shao, Wen-Long Wang, Qi Wang, Zhi-Qiang Chen

J Environ Manage· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer Patients.
Wanting Shao, Melitta B Köpke, Theresa Vilsmaier, Alaleh Zati Zehni, Mirjana Kessler

Cells· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.
Wanting Shao, Christina Kuhn, Doris Mayr, Nina Ditsch, Magdalena Kailuwait

J Cancer Res Clin Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.
Wanting Shao, Christina Kuhn, Doris Mayr, Nina Ditsch, Magdalena Kailuwait

J Cancer Res Clin Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers.
Wanting Shao, Christina Kuhn, Doris Mayr, Nina Ditsch, Magdalena Kailuwait

J Transl Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer.
Wanting Shao, Christina Kuhn, Doris Mayr, Nina Ditsch, Magdalena Kailuweit

Int J Mol Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pursuing shell-isolated nanoparticle-enhanced Raman spectroscopy (SHINERS) for concomitant detection of breast lesions and microcalcifications.
Chao Zheng, Wanting Shao, Santosh Kumar Paidi, Bing Han, Tong Fu

Nanoscale· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis